Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Well Corporation stock logo
AMWL
American Well
$6.84
+2.2%
$7.14
$5.00
$12.95
$106.30M1.1885,209 shs17,928 shs
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
$6.37
$0.38
$1.24
$26.05M0.91522,308 shs466,373 shs
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$0.71
+1.1%
$0.75
$0.66
$3.09
$89.31M1.43128,106 shs625,153 shs
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
$0.70
+2.0%
$0.80
$0.56
$4.38
$110.21M10.67287,221 shs411,070 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Well Corporation stock logo
AMWL
American Well
0.00%-4.60%-8.68%-12.31%-7.01%
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
0.00%0.00%0.00%0.00%0.00%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
0.00%-0.80%-13.87%-28.48%-70.62%
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
0.00%+1.28%-10.89%+6.99%-77.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Well Corporation stock logo
AMWL
American Well
3.7834 of 5 stars
4.13.00.00.03.12.51.3
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
2.1183 of 5 stars
3.02.00.00.00.64.20.6
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Well Corporation stock logo
AMWL
American Well
2.14
Hold$9.6741.33% Upside
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
0.00
N/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
2.00
Hold$2.13200.14% Upside
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CLBS, AMWL, NAUT, and ZJYL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
American Well Corporation stock logo
AMWL
American Well
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$10.00 ➝ $8.00
5/8/2025
American Well Corporation stock logo
AMWL
American Well
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $9.00
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$10.00 ➝ $8.00
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/10/2025
American Well Corporation stock logo
AMWL
American Well
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$12.00 ➝ $7.50
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Well Corporation stock logo
AMWL
American Well
$254.36M0.42N/AN/A$20.31 per share0.34
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/A$1.54 per shareN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/A$1.66 per shareN/A
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
$23.50M4.69$0.03 per share27.88$0.18 per share3.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Well Corporation stock logo
AMWL
American Well
-$208.14M-$10.19N/AN/AN/A-59.13%-48.36%-35.36%7/30/2025 (Estimated)
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
-$27.47M-$0.41N/AN/AN/AN/A-27.24%-26.08%N/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
$3.68MN/A0.00N/AN/AN/AN/AN/A

Latest CLBS, AMWL, NAUT, and ZJYL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
American Well Corporation stock logo
AMWL
American Well
-$3.09-$1.73+$1.36-$1.19$60.15 million$66.83 million
4/29/2025Q1 2025
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.14-$0.13+$0.01-$0.13N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Well Corporation stock logo
AMWL
American Well
N/AN/AN/AN/AN/A
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/AN/A
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Well Corporation stock logo
AMWL
American Well
N/A
2.92
2.89
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/A
22.33
22.33
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/A
17.36
17.36
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
N/A
2.50
2.19

Institutional Ownership

CompanyInstitutional Ownership
American Well Corporation stock logo
AMWL
American Well
56.05%
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
15.57%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
50.71%
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
American Well Corporation stock logo
AMWL
American Well
1,04015.61 million13.77 millionOptionable
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
2760.58 million59.25 millionOptionable
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
130126.15 million74.30 millionOptionable
Jin Medical International Ltd. stock logo
ZJYL
Jin Medical International
245156.55 millionN/ANot Optionable

Recent News About These Companies

Wuhan Jin Jiang International Hotel

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Well stock logo

American Well NYSE:AMWL

$6.84 +0.15 (+2.24%)
Closing price 06/18/2025 03:58 PM Eastern
Extended Trading
$6.81 -0.03 (-0.44%)
As of 06/18/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Caladrius Biosciences stock logo

Caladrius Biosciences NASDAQ:CLBS

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Nautilus Biotechnology stock logo

Nautilus Biotechnology NASDAQ:NAUT

$0.71 +0.01 (+1.06%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$0.71 0.00 (-0.14%)
As of 06/18/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Jin Medical International stock logo

Jin Medical International NASDAQ:ZJYL

$0.70 +0.01 (+2.03%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$0.70 -0.01 (-1.28%)
As of 06/18/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.